SCHEMBL408006

SCHEMBL408006

CCc1cc(C(F)(C(F)(F)F)C(F)(F)F)cc(C)c1NC(=O)c1cccc(N)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.62
ALDH1A1 P00352 2/20 0.62
PTGS1 P23219 6/20 0.50
HSD17B10 Q99714 2/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GAA P10253 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
LCK P06239 1/20 0.39
BLK P51451 1/20 0.39
BTK Q06187 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2008830 0.94 ALDH1A1 (0.70) KDM4EALDH1A1PTGS1HSD17B10MAPT
SCHEMBL1843940 0.91 PTGS1 (0.56) KDM4EALDH1A1PTGS1HSD17B10MAPT
SCHEMBL1275245 0.88 KCNK3 (0.50) KDM4EALDH1A1HSD17B10MAPTHPGD
SCHEMBL406940 0.85 PTGS1 (0.51) KDM4EALDH1A1PTGS1HSD17B10MAPT
SCHEMBL19240497 0.85 PTGS1 (0.54) KDM4EALDH1A1PTGS1HSD17B10SMN1; SMN2
SCHEMBL404470 0.85 PTGS1 (0.51) KDM4EALDH1A1PTGS1HSD17B10MAPT
SCHEMBL2007524 0.83 PTGS1 (0.49) KDM4EALDH1A1PTGS1HSD17B10MAPT
SCHEMBL1274944 0.83 HDAC3 (0.40) KDM4EALDH1A1PTGS1HSD17B10MAPT
SCHEMBL3025979 0.82 MAPT (0.43) KDM4EALDH1A1HSD17B10MAPTHPGD
SCHEMBL1274926 0.82 MAPT (0.39) KDM4EALDH1A1HSD17B10MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8541473-B2 3-aminoxalyl-aminobenzamide derivatives and insecticidal and miticidal agents containing same as active ingredient AGRO-KANESHO CO., LTD. (JP) 2013-09-24 US disclosed
US-8389767-B2 Processes and compounds SYNGENTA CROP PROTECTION LLC (US) 2013-03-05 US disclosed
US-8389767-B2 Processes and compounds SYNGENTA CROP PROTECTION LLC (US) 2013-03-05 US disclosed
US-8389767-B2 Processes and compounds SYNGENTA CROP PROTECTION LLC (US) 2013-03-05 US disclosed
EP-2535327-A1 Insecticidal 3-acylaminobenzanilides Bayer CropScience AG (DE) 2012-12-19 EP disclosed
US-20120022263-A1 3-AMINOXALYL-AMINOBENZAMIDE DERIVATIVES AND INSECTICIDAL AND MITICIDAL AGENTS CONTAINING SAME AS ACTIVE INGREDIENT AGRO-KANESHO CO., LTD. (JP) 2012-01-26 US disclosed
US-7964735-B2 Insecticidal 3-acylaminobenzanilides BAYER CROPSCIENCE AG (DE) 2011-06-21 US disclosed
US-20100204504-A1 NOVEL PROCESSES AND COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2010-08-12 US disclosed
US-20100204504-A1 NOVEL PROCESSES AND COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2010-08-12 US disclosed
US-20100204504-A1 NOVEL PROCESSES AND COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2010-08-12 US disclosed
EP-2183212-A1 NOVEL PROCESSES AND COMPOUNDS Syngenta Participations AG (CH) 2010-05-12 EP disclosed
US-20090215623-A1 Insecticidal 3-acylaminobenzanilides BAYER CROPSCIENCE AG (DE) 2009-08-27 US disclosed
WO-2009030457-A1 NOVEL PROCESSES AND COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2009-03-12 WO disclosed
WO-2009030457-A1 NOVEL PROCESSES AND COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2009-03-12 WO disclosed
EP-1912933-A1 INSECTICIDAL 3-ACYLAMINOBENZANILIDES Bayer CropScience AG (DE) 2008-04-23 EP disclosed
WO-2007017075-A1 INSECTICIDAL 3-ACYLAMINOBENZANILIDES BAYER CROPSCIENCE AG (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022263-A1 3-AMINOXALYL-AMINOBENZAMIDE DERIVATIVES AND INSECTICIDAL AND MITICIDAL AGENTS CONTAINING SAME AS ACTIVE INGREDIENT HDHD5, CBR3, BAK1 KDM4E 399/4885ALDH1A1 889/4885PTGS1 3471/4885
US-20090215623-A1 Insecticidal 3-acylaminobenzanilides CBR3, AADAC, DDT KDM4E 1914/4885ALDH1A1 1739/4885PTGS1 4123/4885
US-20100204504-A1 NOVEL PROCESSES AND COMPOUNDS DDT, CYP4B1, CYP4F3 KDM4E 1085/4885ALDH1A1 351/4885PTGS1 3257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.